These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 32420649

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
    Inoue T, Sasai K, Kitagawa T, Nishimura A, Inada I.
    Psychiatry Clin Neurosci; 2020 Feb; 74(2):140-148. PubMed ID: 31725942
    [Abstract] [Full Text] [Related]

  • 4. Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine.
    Nierenberg AA, Loft H, Olsen CK.
    J Affect Disord; 2019 May 01; 250():35-42. PubMed ID: 30826492
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
    Jain R, Mahableshwarkar AR, Jacobsen PL, Chen Y, Thase ME.
    Int J Neuropsychopharmacol; 2013 Mar 01; 16(2):313-21. PubMed ID: 22963932
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.
    Christensen MC, Loft H, McIntyre RS.
    J Affect Disord; 2018 Feb 01; 227():787-794. PubMed ID: 29689693
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2006 Sep 01; 22(9):1703-13. PubMed ID: 16968574
    [Abstract] [Full Text] [Related]

  • 12. l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Shamabadi A, Kafi F, Arab Bafrani M, Asadigandomani H, A Basti F, Akhondzadeh S.
    J Affect Disord; 2023 Jul 15; 333():38-43. PubMed ID: 37084960
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial.
    Farajollahi-Moghadam M, Sanjari-Moghaddam H, Ghazizadeh Hasemi M, Sanatian Z, Talaei A, Akhondzadeh S.
    Int Clin Psychopharmacol; 2021 May 01; 36(3):140-146. PubMed ID: 33724254
    [Abstract] [Full Text] [Related]

  • 14. Sertraline treatment of major depression in patients with acute MI or unstable angina.
    Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M, Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group.
    JAMA; 2002 Aug 14; 288(6):701-9. PubMed ID: 12169073
    [Abstract] [Full Text] [Related]

  • 15. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 14; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study.
    Wang J, Liu XF, Feng C, Bao Q, Fu HR.
    Int J Psychiatry Clin Pract; 2019 Nov 14; 23(4):245-250. PubMed ID: 29113521
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo.
    Fourrier C, Sampson E, Mills NT, Baune BT.
    Trials; 2018 Aug 20; 19(1):447. PubMed ID: 30126458
    [Abstract] [Full Text] [Related]

  • 18. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH, Lin SH, Jang FL.
    J Clin Psychopharmacol; 2011 Oct 20; 31(5):563-8. PubMed ID: 21869699
    [Abstract] [Full Text] [Related]

  • 19. Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial.
    Mowla A, Dastgheib SA, Razeghian Jahromi L.
    Clin Drug Investig; 2016 Jul 20; 36(7):539-43. PubMed ID: 27071759
    [Abstract] [Full Text] [Related]

  • 20. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial.
    Gao L, Wu C, Liao Y, Wang J.
    J Affect Disord; 2020 Mar 15; 265():99-103. PubMed ID: 32090788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.